Premium
Postoperative radioactive iodine evaluation of total thyroidectomy for thyroid carcinoma: Reappraisal and therapeutic implications
Author(s) -
Attie Joseph N.,
Bock George,
Moskowitz Gerard W.,
Margouleff Donald,
Dubner Sanford
Publication year - 1992
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.2880140408
Subject(s) - medicine , radioactive iodine , ablative case , iodine , thyroidectomy , total thyroidectomy , occult , surgery , thyroid carcinoma , nuclear medicine , thyroid , radiology , radiation therapy , pathology , materials science , alternative medicine , metallurgy
The records of 430 patients who underwent total thyroidectomy with radioactive iodine (RAI) uptake studies performed postop‐eratively were reviewed. Indications for the administration of an ablative dose of iodine 131 are given. The majority (85.4%) had no or low (less than 2%) evidence of focal uptake and therefore were not treated with ablative doses of iodine 131. RAI scanning is necessary postoperatively to determine the completeness of the surgical procedure and to detect residual or metastatic disease. Small foci of residual disease or occult distant metastases can be adequately treated with therapeutic doses of RAI. Nodal or distant metastases that become clinically evident following thyroidectomy are usually not successfully treated with RAI. © John Wiley & Sons, Inc.